Advanced Pharmacology – Module 6 H5P Teacher Questions & Exam Review (Diabetes, Insulin Management & Drug Safety) Complete Verified Questions Provided with A+ Graded Rationales Latest Updated 2026

Advanced Pharmacology – Module 6 H5P Teacher Questions & Exam Review (Diabetes, Insulin Management & Drug Safety) Complete Verified Questions Provided with A+ Graded Rationales Latest Updated 2026 John comes in with random glucose of 250? Does any further testing for DM need to be done? Yes or No No SGLT-2 inhibitors should not be given if GFR 35. True or False True What do you do if an individual has: High FBG levels? NPH dose needs to be increased What do you do if an individual has: Hyperglycemia after breakfast The person has not received enough short-acting (SA) insulin or too many carbs or calories at the meal. What do you do if an individual has: Hypoglycemia before lunch Intermediate-acting insulin is peaking before their lunch has been eaten, or the patient is not eating enough breakfast. What do you do if an individual has: Hypoglycemia in the afternoon It's from the peak and fail of intermediate acting insulin What do you do if an individual has: Hyperglycemia in the afternoon Intermediate acting insulin needs to be increased or the size of lunch was too large What do you do if an individual has: Hyperglycemia after evening meal. The dose of short acting insulin needs to be increased. What do you do if an individual has: Hypoglycemia overnight (2-3 am) The afternoon dose of NPH is peaking and causing low BS. The patient needs less intermediate acting insulin. A 35-year-old is a T1DM since age 12. She takes NPH 10 units at breakfast, Novolog 6 units at Breakfast and Lunch, 10 Units at supper, and 18 units NPH at HS. • What is the total amount of NPH per day? • What is the total amount of Novolog per day? • If you wanted to start her on Glargine insulin, what would be the initial dose? 28 U 22 U 28 U unless you want to start at 80%, then 22 U Which of the following medications cannot be used in gestational diabetes? A. Insulin B. Metformin C. Glucotrol C. Glucotrol Jane has type 1 diabetes and is taking a beta-blocker. What does she need to be aware of? A. Non cardioselective beta blockers do not affect glycogenolysis B. Non-cardioselective beta blockers increase glycogenolysis and help the body counteract a fall in glucose. C. Non cardioselective beta blockers impair glycogenolysis, and glycogenolysis is a means by which the body can respond to and counteract a fall in blood glucose D. Non-cardioselective beta blockers can make a patient more aware of hypoglycemia C. Non cardioselective beta blockers impair glycogenolysis, and glycogenolysis is a means by which the body can respond to and counteract a fall in blood glucose Gina is taking Canagliflozin for her diabetes. The NP tells her this may increase her risk for: